| Title | Precision Cancer Medicine |
| Abbreviation | Precis. Cancer Med. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Anesthesiology and Pain Medicine (Q3); Oncology (Q3); Oncology (nursing) (Q3); Pharmacology (medical) (Q3); Surgery (Q3); Cancer Research (Q4) |
| h-index | 10 |
| Overall Rank/Ranking | 15858 |
| SCImago Journal Rank (SJR) | 0.326 |
| Impact Score | 0.82 |
| Publisher | AME Publishing Company |
| Country | China |
| ISSN | 26172216 |
| Best Quartile | Q3 |
| Coverage History | 2018-2024 |
Precision Cancer Medicine is a journal covering the technologies/fields/categories related to Anesthesiology and Pain Medicine (Q3); Oncology (Q3); Oncology (nursing) (Q3); Pharmacology (medical) (Q3); Surgery (Q3); Cancer Research (Q4). It is published by AME Publishing Company. The overall rank of Precision Cancer Medicine is 15858. According to SCImago Journal Rank (SJR), this journal is ranked 0.326. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 10. The best quartile for this journal is Q3.
The ISSN of Precision Cancer Medicine journal is 26172216. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Precision Cancer Medicine is cited by a total of 87 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Precision Cancer Medicine is 0.82, which is computed in 2025 as per its definition. Precision Cancer Medicine IF is increased by a factor of 0.07 and approximate percentage change is 9.33% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Precision Cancer Medicine is 0.82. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.82 |
| 2023 | 0.75 |
| 2022 | 0.69 |
| 2021 | 0.35 |
| 2020 | 0.17 |
| 2019 | 0.05 |
| 2018 | 0.00 |
Precision Cancer Medicine has an h-index of 10. It means 10 articles of this journal have more than 10 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Precision Cancer Medicine is 26172216. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Precision Cancer Medicine is 15858. According to SCImago Journal Rank (SJR), this journal is ranked 0.326. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.326 |
| 2023 | 0.409 |
| 2022 | 0.190 |
| 2021 | 0.219 |
| 2020 | |
| 2019 | |
| 2018 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 15858 |
| 2023 | 12801 |
| 2022 | 19716 |
| 2021 | 17678 |
| 2020 | 34470 |
| 2019 | 32186 |
| 2018 | 33678 |
Precision Cancer Medicine is published by AME Publishing Company. It's publishing house is located in China. Coverage history of this journal is as following: 2018-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Precision Cancer Medicine is Precis. Cancer Med.. This abbreviation ('Precis. Cancer Med.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Anesthesiology and Pain Medicine (Q3); Oncology (Q3); Oncology (nursing) (Q3); Pharmacology (medical) (Q3); Surgery (Q3); Cancer Research (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Precision Cancer Medicine latest impact IF is 0.82. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.82 (2024) and 0.00 (2018), respectively, in the last 7 years. Moreover, its average IS is 0.4 in the previous 7 years.
The Precision Cancer Medicine has an SJR (SCImago Journal Rank) of 0.326, according to the latest data. It is computed in the year 2025. In the past 7 years, this journal has recorded a range of SJR, with the highest being 0.409 in 2023 and the lowest being in 2020. Furthermore, the average SJR of the Precision Cancer Medicine over the previous 7-year period stands at 0.4.
The latest h-index of the Precision Cancer Medicine is 10.
The Precision Cancer Medicine is published by the AME Publishing Company, with its country of publication being the China.
The Precision Cancer Medicine is currently ranked 15858 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 7 years, this journal has experienced varying rankings, reaching its highest position of 12801 in 2023 and its lowest position of 34470 in 2020.
The standard ISO4 abbreviation for the Precision Cancer Medicine is Precis. Cancer Med..
Precision Cancer Medicine is classified as a journal that the AME Publishing Company publishes.
The Precision Cancer Medicine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Precision Cancer Medicine is assigned the following International Standard Serial Numbers (ISSN): 26172216.
The best quartile for the Precision Cancer Medicine is Q3 (2024).
The Precision Cancer Medicine coverage history can be summarized as follows: 2018-2024.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| Current Sociology | journal | 5151 | SAGE Publications Ltd | 86 | 3.02 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Journal of Supply Chain Management | journal | 331 | Wiley-Blackwell | 119 | 9.76 |
| Tekstilec | trade journal | 17340 | University of Ljubljana Press | 16 | 1.29 |
| Asian Textile Journal | trade journal | 25375 | G P S Kwatra | 11 | 0.08 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| European Journal of Wildlife Research | journal | 10254 | Springer Verlag | 62 | 1.99 |
| Transboundary and Emerging Diseases | journal | 5531 | John Wiley and Sons Ltd | 92 | 3.26 |
| Journal of Medical Toxicology | journal | 5436 | Springer New York | 64 | 1.71 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.82 |
| 2023 | 0.75 |
| 2022 | 0.69 |
| 2021 | 0.35 |
| 2020 | 0.17 |
| 2019 | 0.05 |
| 2018 | 0.00 |
